Use of tetravalent galabiose for inhibition of streptococcus suis serotype 2 infection in a mouse model

about

Structural basis of the interaction between the meningitis pathogen Streptococcus suis adhesin Fhb and its human receptor Targeting TREM-1 Signaling in the Presence of Antibiotics is Effective Against Streptococcal Toxic-Shock-Like Syndrome (STSLS) Caused by Streptococcus suis

P2860

Q27704647-D1DDA01F-7965-4249-8BD6-EF554FBC0037 Q36271812-BBB4AA40-43D0-4B6C-B82F-036A1DA65B93

P2860

Use of tetravalent galabiose for inhibition of streptococcus suis serotype 2 infection in a mouse model

Item

http://www.wikidata.org/entity/Q37651483

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 April 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Use of tetravalent galabiose f ...... e 2 infection in a mouse model

@en

Use of tetravalent galabiose f ...... 2 infection in a mouse model.

@nl

type

Item

label

Use of tetravalent galabiose f ...... e 2 infection in a mouse model

@en

Use of tetravalent galabiose f ...... 2 infection in a mouse model.

@nl

prefLabel

Use of tetravalent galabiose f ...... e 2 infection in a mouse model

@en

Use of tetravalent galabiose f ...... 2 infection in a mouse model.

@nl

P1476

Use of tetravalent galabiose f ...... e 2 infection in a mouse model

@en

P2093

Hanne Møller Mortensen

http://www.w3.org/2001/XMLSchema#string

Hilbert M Branderhorst

http://www.w3.org/2001/XMLSchema#string

John A F Joosten

http://www.w3.org/2001/XMLSchema#string

Lene Arler

http://www.w3.org/2001/XMLSchema#string

Sauli Haataja

http://www.w3.org/2001/XMLSchema#string

P2860

Differences in the population structure of invasive Streptococcus suis strains isolated from pigs and from humans in The Netherlands

The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions.

A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.

Streptococcus suis interactions with the murine macrophage cell line J774: adhesion and cytotoxicity.

Streptococcus suis infection.

Hemagglutination activities of group B, C, D, and G streptococci: demonstration of novel sugar-specific cell-binding activities in Streptococcus suis

The galactosyl-(alpha 1-4)-galactose-binding adhesin of Streptococcus suis: occurrence in strains of different hemagglutination activities and induction of opsonic antibodies.

Extracellular virulence factors of streptococci associated with animal diseases.

Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides

Experimental studies on the comparative infectivity and pathogenicity of Streptococcus suis type 2. II. Porcine and human isolates in laboratory animals.

P304

702-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/BIOLOGY2020702

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karen A. Krogfelt

Hans-Christian Slotved

Roland J. Pieters

Jukka Finne

P577

2013-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262382040

http://www.w3.org/2001/XMLSchema#string

P698

24832804

http://www.w3.org/2001/XMLSchema#string

P932

3960886

http://www.w3.org/2001/XMLSchema#string

Use of tetravalent galabiose for inhibition of streptococcus suis serotype 2 infection in a mouse model

about

P2860

P2860

Use of tetravalent galabiose for inhibition of streptococcus suis serotype 2 infection in a mouse model

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932